New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

FDA Says to Stop Selling Vaginal Mesh

An increase in ‘adverse events’ linked to surgical mesh used in pelvic procedures prompts action from the FDA.

FDA / Image: Andrew Harnik
FDA / Image: Andrew Harnik

For the past few years, the FDA has been investigating the safety of surgical mesh used for repairing a condition called pelvic organ prolapse. A recent article from The Washington Post contained the latest development stating that the FDA has ordered manufacturers to immediately stop selling the products. This includes Boston Scientific and Coloplast, neither of which has demonstrated a “reasonable assurance” of safety and effectiveness for long-term use of the devices. The companies have 10 days to submit plans for withdrawing them from the market.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts